v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 35,295 $ 56,307
Marketable securities 34,106 46,613
Accounts receivable net of allowance for credit losses of $1,269 and $1,230, respectively 17,888 19,179
Other receivables 2,661 2,526
Inventory 687 866
Prepaid expenses and other current assets 1,833 2,401
Land held for sale 9,114 11,282
Total current assets 101,584 139,174
Property, plant, and equipment, net 229,068 203,919
Operating lease right-of-use asset 3,357 3,735
Intangible assets, net 60 73
Deferred tax assets 496 621
Other long-term assets 13,812 30,505
Total assets 348,377 378,027
Current liabilities    
Accounts payable 2,083 2,921
Accrued expenses 11,351 2,779
Operating lease liabilities, current 336 323
Notes payable, short-term 1,730 3,772
Other liabilities, current 441 2,754
Total current liabilities 15,941 12,549
Earnout liability 24 2,486
Canadian Government Research and Development Program liability 15,132 14,399
Common stock warrants liability 681 4,566
Notes payable, long-term 1,730 1,730
Operating lease liabilities 3,689 3,858
Other liabilities, long-term 54 74
Total liabilities 37,251 39,662
Commitments and contingencies (See Note 16)
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding as of June 30, 2025 and December 31, 2024 0 0
Common stock, $0.0001 par value, 1,000,000,000 shares authorized; 150,173,853 and 148,574,227, issued and outstanding as of June 30, 2025 and December 31, 2024, respectively (including 3,000,000 of Sponsor Vesting Shares) 15 15
Additional paid-in capital 397,812 393,186
Accumulated deficit (77,315) (38,127)
Accumulated other comprehensive loss (9,386) (16,709)
Total stockholders’ equity 311,126 338,365
Total liabilities and stockholders’ equity $ 348,377 $ 378,027